{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:30:22Z","timestamp":1784788222432,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.clinthera.2011.10.024","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T08:09:45Z","timestamp":1323072585000},"page":"2038-2053","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacokinetic Comparison of Sustained- and Immediate-Release Oral Formulations of Cilostazol in Healthy Korean Subjects: A Randomized, Open-Label, 3-Part, Sequential, 2-Period, Crossover, Single-Dose, Food-Effect, and Multiple-Dose Study"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct01455558","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Donghwan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lay Ahyoung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Bok","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Rak","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosang","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungsoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2011.10.024_bib1","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1463-1326.2002.0040s2s14.x","article-title":"The pharmacology of cilostazol","volume":"4","author":"Schror","year":"2002","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2011.10.024_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1527-3466.2001.tb00076.x","article-title":"Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake","volume":"19","author":"Liu","year":"2001","journal-title":"Cardiovasc Drug Rev"},{"issue":"1","key":"10.1016\/j.clinthera.2011.10.024_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003748.pub3","article-title":"Cilostazol for the peripheral arterial disease","author":"Robless","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2011.10.024_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","article-title":"Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial","volume":"98","author":"Dawson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2011.10.024_bib5","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/CIRCULATIONAHA.104.530097","article-title":"Coronary stent restenosis in patients treated with cilostazol","volume":"112","author":"Douglas","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2011.10.024_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.fjc.0000167012.82930.8f","article-title":"RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome","volume":"46","author":"Ge","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.clinthera.2011.10.024_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosissup.2005.09.003","article-title":"Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study","volume":"6","author":"Matsumoto","year":"2005","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.clinthera.2011.10.024_bib8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.STR.0000157667.06542.b7","article-title":"Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis","volume":"36","author":"Kwon","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2011.10.024_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ahj.2009.11.014","article-title":"Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)","volume":"159","author":"Lee","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2011.10.024_bib13","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00216-005-0198-z","article-title":"Simultaneous quantification of cilostazol and its primary metabolite 3,4-dehydrocilostazol in human plasma by rapid liquid chromatography\/tandem mass spectrometry","volume":"384","author":"Nirogi","year":"2006","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.clinthera.2011.10.024_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0731-7085(98)00052-1","article-title":"The quantitative determination of cilostazol and its four metabolites in human liver microsomal incubation mixtures by high-performance liquid chromatography","volume":"18","author":"Tata","year":"1998","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.clinthera.2011.10.024_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0731-7085(01)00436-8","article-title":"Method for the quantitative analysis of cilostazol and its metabolites in human plasma using LC\/MS\/MS","volume":"26","author":"Bramer","year":"2001","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.clinthera.2011.10.024_bib17","first-page":"161","article-title":"Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications","author":"Gabrielsson","year":"2006"},{"key":"10.1016\/j.clinthera.2011.10.024_bib18","series-title":"Guidance for Industry","year":"2003"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2011.10.024_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-199937002-00002","article-title":"Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics","volume":"37","author":"Bramer","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2011.10.024_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/j.1552-4604.1998.tb04403.x","article-title":"Pharmacokinetics of multiple-dose oral cilostazol in middle-age and elderly men and women","volume":"38","author":"Suri","year":"1998","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2011.10.024_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199937002-00001","article-title":"Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease","volume":"37","author":"Bramer","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2011.10.024_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF03190458","article-title":"Chronopharmacokinetics of acetaminophen in healthy human volunteers","volume":"27","author":"Kolawole","year":"2002","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.clinthera.2011.10.024_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/17425255.4.2.175","article-title":"The influence of circadian rhythms on the kinetics of drugs in humans","volume":"4","author":"Baraldo","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clinthera.2011.10.024_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clinthera.2007.01.016","article-title":"A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults","volume":"29","author":"Park","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.10.024_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2114\/jpa2.25.29","article-title":"Seasonal variations of physiological characteristics and thermal sensation under identical thermal conditions","volume":"25","author":"Umemiya","year":"2006","journal-title":"J Physiol Anthropol"},{"key":"10.1016\/j.clinthera.2011.10.024_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2114\/jpa2.29.141","article-title":"Seasonal variation in amount of unabsorbed dietary carbohydrate from the intestine after breakfast in young female Thai subjects: comparison with that of Japanese subjects","volume":"29","author":"Tsumura","year":"2010","journal-title":"J Physiol Anthropol"},{"key":"10.1016\/j.clinthera.2011.10.024_bib28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/vr.112.16.379","article-title":"Pharmacokinetics and urinary excretion of sulphadimidine in sheep during summer and winter","volume":"112","author":"Nawaz","year":"1983","journal-title":"Vet Rec"},{"key":"10.1016\/j.clinthera.2011.10.024_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0016-6480(84)90247-8","article-title":"Seasonal changes in the metabolic clearance rate of cortisol in the adult male sand rat (Psammomys obesus)","volume":"53","author":"Amirat","year":"1984","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.clinthera.2011.10.024_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1530\/jrf.0.0710235","article-title":"Seasonal changes in testicular contents of testosterone and androstenedione and in the metabolic clearance rate of testosterone in the sand rat (Psammomys obesus)","volume":"71","author":"Khammar","year":"1984","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.clinthera.2011.10.024_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0893-133X(95)00183-E","article-title":"Seasonal variation in platelet [3H]paroxetine binding in healthy volunteers","volume":"15","author":"D'Hondt","year":"1996","journal-title":"Neuropsychopharmacology"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811007132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811007132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T05:23:38Z","timestamp":1543382618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811007132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0149291811007132"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.10.024","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}